P53 and EGFR expression in colorectal cancer: a reappraisal of 'old' tissue markers in patients with long follow-up.

George Theodoropoulos, Eleni Karafoka, Joanna G. Papailiou, Paraskevas Stamopoulos, Constantinos P. Zambirinis, Konstantinos Bramis, Sotirios-George Panoussopoulos, John Bramis

PubMed · 2009 · 44 citations · 37 references

Abstract

p53 and EGFR were overexpressed in this colorectal cancer patient population and were significantly associated with advanced T stage. In the context of new therapeutic strategies using EGFR-targeted therapies, although EGFR remains a controversial prognostic factor, this expression-stage association may play a crucial role in a decision to initiate an adjuvant treatment.

References

37